Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2025 ▲▼ | Q3 2025 ▲▼ | Change ▲▼ | Q2 2025 ▲▼ | Q3 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Arcellx, Inc. COMMON STOCK | 2,346,630 | 2,346,630 | 0 | $154.53M | $192.66M | 27.86% | +$38.13M |
| CRISPR Therapeutics AG(CRSP) | 1,048,951 | 2,038,763 | +989,812 | $51.02M | $132.13M | 19.11% | +$81.11M |
| Zenas BioPharma, Inc.(ZBIO) | 4,911,539 | 4,911,539 | 0 | $47.59M | $109.04M | 15.77% | +$61.44M |
| Mineralys Therapeutics, Inc.(MLYS) | 3,127,933 | 2,113,933 | -1,014,000 | $42.32M | $80.16M | 11.59% | +$37.84M |
| ORIC Pharmaceuticals, Inc.(ORIC) | 4,514,929 | 4,514,929 | 0 | $45.83M | $54.18M | 7.84% | +$8.35M |
| Design Therapeutics, Inc.(DSGN) | 6,526,476 | 6,526,476 | 0 | $21.99M | $49.14M | 7.11% | +$27.15M |
| ARS Pharmaceuticals, Inc.(SPRY) | 4,012,903 | 4,012,903 | 0 | $70.03M | $40.33M | 5.83% | -$29.70M |
| Oruka Therapeutics, Inc.(ORKA) | 430,330 | 430,330 | 0 | $4.82M | $8.28M | 1.20% | +$3.45M |
| Alumis Inc. | 1,959,896 | 1,959,896 | 0 | $5.88M | $7.82M | 1.13% | +$1.94M |
| Nkarta, Inc.(NKTX) | 3,333,333 | 3,333,333 | 0 | $5.53M | $6.90M | 1.00% | +$1.37M |
| Oculis Holding AG(OCS) | 322,500 | 322,500 | 0 | $6.26M | $5.67M | 0.82% | -$590.2K |
| enGene Holdings Inc. COM | 747,750 | 747,750 | 0 | $2.72M | $5.11M | 0.74% | +$2.39M |
| KALA BIO, Inc.(KALA) | 598,940 | 0 | -598,940 | $2.85M | $0 | — | -$2.85M |